MyMD Pharmaceuticals Inc
(NAS:MYMD)
$
1.9
0.09 (4.97%)
Market Cap: 4.50 Mil
Enterprise Value: 2.74 Mil
PE Ratio: 0
PB Ratio: 0.42
GF Score: 37/100 - MyMD Pharmaceuticals Inc Phase 2 Trial Update Call TranscriptAug 02, 2023
- MyMD Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJul 31, 2023
- MyMD Pharmaceuticals Inc Annual Shareholders Meeting TranscriptDec 14, 2022
- MyMD Pharmaceuticals Inc Annual Shareholders Meeting TranscriptDec 29, 2021
- MyMD Pharmaceuticals Inc at Benzinga Global Small Cap Investor Conference (Virtual) TranscriptDec 08, 2021
- MyMD Pharmaceuticals Inc at Dawson James Small Cap Growth Stock Conference (Virtual) TranscriptOct 21, 2021
- MyMD Pharmaceuticals Inc at Benzinga Virtual Global Small Cap Conference TranscriptMay 13, 2021
MyMD Pharmaceuticals Inc at Benzinga Global Small Cap Investor Conference (Virtual) Transcript
Dec 08, 2021 / 09:00PM GMT
Release Date Price:
$210.9
(+1.01%)
Spencer Israel
Benzinga - Moderator
All right. Let's move on here, and let's bring on Dr. Adam Kaplin, the Chief Scientific Officer of MyMD Pharmaceuticals. There he is. How are we doing today?
Adam Kaplin
MyMD Pharmaceuticals, Inc. - Chief Scientific Officer
Good. How are you, Spencer?
Spencer Israel
Benzinga - Moderator
Doing great, doing great. It's been a minute since we caught up. So good to see you again. I hope your Thanksgiving was well. Let's bring his slides up on the screen, guys. There we go.
And Adam, take it away.
Adam Kaplin
MyMD Pharmaceuticals, Inc. - Chief Scientific Officer
Thanks so much. I also to wanted to make sure that my colleague, Rob, who's the brainchild about all things financial, is hiding in the wings. So he's my fall guy. He's my net, and I never performed without a net.
Spencer Israel
Benzinga - Moderator
He is lurking backstage. Yes, we'll bring him on a little bit.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)